HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function
Immunology Letters · 2023
DOI: 10.1016/j.imlet.2023.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2023. Verfasst von Syed Bilal Ahmad Andrabi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; InFLAMES Research Flagship Center, University of Turku. Hauptthemen laut MEDLINE: Immunosuppression Therapy, Lymphocyte Activation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Transcriptional repressor, hypermethylated in cancer 1 (HIC1) participates in a range of important biological processes, such as tumor repression, immune suppression, embryonic development and epigenetic gene regulation. Further to these, we previously demonstrated that HIC1 provides a significant contribution to the function and development of regulatory T (Treg) cells. However, the mechanism by which it regulates these processes was not apparent. To address this question, we used affinity-purification mass spectrometry to characterize the HIC1 interactome in human Treg cells. Altogether 61 high-confidence interactors were identified, including IKZF3, which is a key transcription factor in the development of Treg cells. The biological processes associated with these interacting proteins include protein transport, mRNA processing, non-coding (ncRNA) transcription and RNA metabolism. The results revealed that HIC1 is part of a FOXP3-RUNX1-CBFB protein complex that regulates Treg signature genes thus improving our understanding of HIC1 function during early Treg cell differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; InFLAMES Research Flagship Center, University of Turku.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; Precision Biomarker Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; InFLAMES Research Flagship Center, University of Turku; Institute of Biomedicine, University of Turku. Electronic address: r…
Zitieren
APA
Andrabi, S. B. A., Batkulwar, K., Bhosale, S. D., Moulder, R., Khan, M. H., Buchacher, T., Khan, M. M., Arnkil, I., Rasool, O., Marson, A., Kalim, U. U., & Lahesmaa, R. (2023). HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function. Immunology Letters. https://doi.org/10.1016/j.imlet.2023.09.001
Vancouver
Andrabi SBA, Batkulwar K, Bhosale SD, Moulder R, Khan MH, Buchacher T, et al. HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function. Immunology Letters. 2023. doi:10.1016/j.imlet.2023.09.001
BibTeX
@article{Andrabi2023,
author = {Andrabi, Syed Bilal Ahmad and Batkulwar, Kedar and Bhosale, Santosh D and Moulder, Robert and Khan, Meraj Hasan and Buchacher, Tanja and Khan, Mohd Moin and Arnkil, Ilona and Rasool, Omid and Marson, Alexander and Kalim, Ubaid Ullah and Lahesmaa, Riitta},
title = {HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function},
journal = {Immunology Letters},
year = {2023},
doi = {10.1016/j.imlet.2023.09.001}
}
EUVIMED